Lassila & Tikanoja plc are entitled to appoint their representatives to the company?s Nomination Board. According to the Charter of the Nomination Board, a group of shareholders may agree on the appointment of a joint representative to the Nomination Board. The following shareholders have agreed on the appointment of a joint representative: Chemec Oy, CH-Polymers Oy, Maijala Eeva, Maijala Hannele, Maijala Heikki, Maijala Juhani, Maijala Juuso, Maijala Miikka, Maijala Mikko, Maijala Roope and Maijala Tuula.

Lassila & Tikanoja plc?s three shareholders, who are entitled to appoint a representative to Lassila & Tikanoja plc?s Shareholders? Nomination Board are the Evald and Hilda Nissin Säätiö foundation, the above-mentioned group of shareholders, and Nordea Funds Ltd. (through 11 funds managed by it). The following persons have been appointed as their representatives in Lassila & Tikanoja?s Nomination Board: Juhani Lassila ?

Chairman of the Board, Evald ja Hilda Nissin Säätiö (9% of shares and votes). Miikka Maijala ? CEO, Clinius Ltd, group of shareholders (8.5% of shares and votes) and Tanja Eronen ?

CEO, Nordea Funds Ltd. (4.7% of shares and votes). The Chairman of Lassila & Tikanoja plc?s Board of Directors, Jukka Leinonen, acts as the fourth member of the Nomination Board. The Chairman of the Nomination Board is Juhani Lassila.

The Nomination Board prepares proposals for board members and board remuneration for the next Annual General Meeting.